KPT vs. CRP, GCL, BU, SWP, ADW.A, CSW.A, BR, CNT, GLG, and HLF
Should you be buying KP Tissue stock or one of its competitors? The main competitors of KP Tissue include Ceres Global (CRP), Colabor Group (GCL), Burcon NutraScience (BU), Swiss Water Decaffeinated Coffee (SWP), Andrew Peller (ADW.A), Corby Spirit and Wine (CSW.A), Big Rock Brewery (BR), Century Global Commodities (CNT), GLG Life Tech (GLG), and High Liner Foods (HLF). These companies are all part of the "consumer defensive" sector.
KP Tissue (TSE:KPT) and Ceres Global (TSE:CRP) are both small-cap consumer defensive companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, community ranking, dividends, earnings, profitability and institutional ownership.
Ceres Global has higher revenue and earnings than KP Tissue. KP Tissue is trading at a lower price-to-earnings ratio than Ceres Global, indicating that it is currently the more affordable of the two stocks.
KP Tissue has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500. Comparatively, Ceres Global has a beta of 0.18, suggesting that its stock price is 82% less volatile than the S&P 500.
In the previous week, KP Tissue had 17 more articles in the media than Ceres Global. MarketBeat recorded 19 mentions for KP Tissue and 2 mentions for Ceres Global. Ceres Global's average media sentiment score of 0.45 beat KP Tissue's score of 0.26 indicating that Ceres Global is being referred to more favorably in the news media.
Ceres Global has a net margin of 0.59% compared to KP Tissue's net margin of 0.00%. Ceres Global's return on equity of 3.93% beat KP Tissue's return on equity.
KP Tissue received 209 more outperform votes than Ceres Global when rated by MarketBeat users. Likewise, 65.14% of users gave KP Tissue an outperform vote while only 63.03% of users gave Ceres Global an outperform vote.
KP Tissue currently has a consensus target price of C$9.70, suggesting a potential upside of 18.00%. Given KP Tissue's higher probable upside, equities analysts clearly believe KP Tissue is more favorable than Ceres Global.
8.7% of KP Tissue shares are held by institutional investors. Comparatively, 69.7% of Ceres Global shares are held by institutional investors. 0.1% of KP Tissue shares are held by insiders. Comparatively, 0.6% of Ceres Global shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Ceres Global beats KP Tissue on 10 of the 16 factors compared between the two stocks.
Get KP Tissue News Delivered to You Automatically
Sign up to receive the latest news and ratings for KPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
KP Tissue Competitors List
Related Companies and Tools